Project
Inflammatory response time course, HUVEC (Wada, 2009)
Navigation
Downloads
Results for MXI1_MYC_MYCN
Z-value: 2.45
Motif logo
Transcription factors associated with MXI1_MYC_MYCN
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MXI1
|
ENSG00000119950.21 | MXI1 |
|
MYC
|
ENSG00000136997.21 | MYC |
|
MYCN
|
ENSG00000134323.12 | MYCN |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MXI1 | hg38_v1_chr10_+_110207587_110207684, hg38_v1_chr10_+_110225955_110226016 | -0.43 | 3.3e-02 | Click! |
| MYCN | hg38_v1_chr2_+_15940537_15940566 | -0.38 | 6.3e-02 | Click! |
| MYC | hg38_v1_chr8_+_127737610_127737626, hg38_v1_chr8_+_127736046_127736084, hg38_v1_chr8_+_127736220_127736241, hg38_v1_chr8_+_127735597_127735659 | 0.06 | 7.9e-01 | Click! |
Activity profile of MXI1_MYC_MYCN motif
Sorted Z-values of MXI1_MYC_MYCN motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MXI1_MYC_MYCN
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.2 | 27.7 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
| 8.0 | 32.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 6.7 | 60.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 3.2 | 13.0 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 3.2 | 9.7 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 3.0 | 15.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 2.8 | 16.8 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.3 | 16.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 2.2 | 6.7 | GO:0070078 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 2.2 | 8.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 2.1 | 2.1 | GO:0006233 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 2.1 | 6.3 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 2.1 | 6.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 2.0 | 5.9 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 1.9 | 7.6 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.9 | 7.5 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 1.8 | 10.9 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.7 | 15.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 1.5 | 7.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.5 | 19.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.5 | 11.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 1.4 | 7.1 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 1.4 | 7.0 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 1.3 | 3.9 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.3 | 3.9 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 1.3 | 3.9 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 1.3 | 1.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 1.3 | 6.4 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 1.3 | 5.1 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.3 | 3.8 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
| 1.3 | 8.8 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 1.3 | 3.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 1.2 | 2.5 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 1.2 | 8.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.2 | 3.6 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
| 1.2 | 3.5 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.2 | 3.5 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 1.1 | 3.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 1.1 | 4.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 1.1 | 5.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 | 3.3 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 1.1 | 3.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 1.0 | 3.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 1.0 | 3.1 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.0 | 4.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.0 | 3.0 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) |
| 1.0 | 4.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.9 | 2.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.9 | 4.6 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.9 | 3.6 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.9 | 3.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.9 | 7.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.8 | 1.7 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 0.8 | 5.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.8 | 4.9 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.8 | 2.4 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.8 | 3.2 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.8 | 8.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.8 | 2.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.8 | 3.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.8 | 2.3 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.8 | 2.3 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.8 | 3.8 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.7 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.7 | 12.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.7 | 4.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.7 | 1.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.7 | 3.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.7 | 0.7 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.7 | 2.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.7 | 2.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.7 | 3.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.7 | 4.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.7 | 6.0 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.7 | 4.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.6 | 1.9 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.6 | 22.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.6 | 6.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.6 | 1.9 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.6 | 4.4 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.6 | 8.0 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.6 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.6 | 2.4 | GO:0072299 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.6 | 1.8 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.6 | 1.8 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.6 | 4.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.6 | 2.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.6 | 1.7 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.6 | 4.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.6 | 3.4 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.6 | 1.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.5 | 2.7 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.5 | 1.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.5 | 2.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.5 | 2.1 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.5 | 7.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.5 | 3.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.5 | 2.0 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.5 | 7.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 1.5 | GO:0018016 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.5 | 2.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.5 | 1.5 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.5 | 1.0 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.5 | 2.0 | GO:0070378 | positive regulation of ERK5 cascade(GO:0070378) |
| 0.5 | 1.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.5 | 2.0 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 | 5.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.5 | 0.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.5 | 1.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.5 | 2.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.5 | 7.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.5 | 6.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 7.6 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 | 3.5 | GO:0097527 | Fas signaling pathway(GO:0036337) necroptotic signaling pathway(GO:0097527) |
| 0.4 | 0.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.4 | 3.0 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.4 | 0.4 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 1.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 3.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 | 1.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.4 | 2.1 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.4 | 7.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 | 0.4 | GO:0044205 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.4 | 2.9 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.4 | 0.4 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 | 2.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.6 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.4 | 5.2 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.4 | 1.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.4 | 4.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 4.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 1.2 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.4 | 1.6 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.4 | 1.2 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.4 | 4.3 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.4 | 1.2 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.4 | 5.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.4 | 3.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.4 | 0.4 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.4 | 3.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.4 | 0.8 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.4 | 1.5 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.4 | 1.9 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.4 | 3.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.4 | 5.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.4 | 1.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.4 | 3.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 | 1.1 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 0.4 | 1.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 6.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.4 | 11.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.4 | 1.8 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.4 | 1.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 | 1.0 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.3 | 1.4 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 | 1.7 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 | 1.0 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.3 | 2.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.3 | 1.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 1.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.3 | 2.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 | 6.6 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 | 1.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 | 1.9 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.3 | 1.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 1.0 | GO:1902227 | regulation of interleukin-4-mediated signaling pathway(GO:1902214) negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) regulation of positive thymic T cell selection(GO:1902232) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
| 0.3 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.3 | 5.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.3 | 1.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 | 3.4 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.3 | 0.3 | GO:0044026 | DNA hypermethylation(GO:0044026) |
| 0.3 | 0.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 | 1.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.3 | 2.1 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.3 | 1.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.3 | 0.9 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.3 | 5.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.3 | 1.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.3 | 1.2 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.3 | 4.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.3 | 5.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.3 | 0.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.3 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.3 | 1.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.3 | 1.8 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 0.3 | 0.9 | GO:1903572 | coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.3 | 0.9 | GO:0061743 | motor learning(GO:0061743) |
| 0.3 | 0.9 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.3 | 1.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 2.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.3 | 3.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.6 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) |
| 0.3 | 1.1 | GO:0035978 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.3 | 0.8 | GO:0044266 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.3 | 6.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 0.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.3 | 2.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 0.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.3 | 1.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.3 | 2.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.3 | 0.5 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.3 | 1.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.3 | 1.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.3 | 0.8 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 | 0.8 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.3 | 0.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 0.3 | 2.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 | 4.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.3 | 1.1 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.3 | 1.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.3 | 4.4 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.3 | 1.0 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.3 | 0.5 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.3 | 0.8 | GO:0061573 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 2.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.3 | 0.8 | GO:0001188 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 | 2.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.3 | 1.0 | GO:1904021 | negative regulation of G-protein coupled receptor internalization(GO:1904021) |
| 0.2 | 0.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 | 4.5 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.2 | 5.7 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.2 | 2.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 1.7 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 2.4 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.2 | 4.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.5 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 | 1.0 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 | 1.4 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.2 | 2.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 1.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.2 | 3.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 0.7 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.2 | 1.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.2 | 0.7 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.2 | 0.9 | GO:0046086 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) adenosine biosynthetic process(GO:0046086) |
| 0.2 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 | 25.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.2 | 0.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 3.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 | 1.1 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.2 | 0.9 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.2 | 1.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 2.5 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 1.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 1.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.2 | 1.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.2 | 1.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 0.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.2 | 0.4 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.2 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.2 | 2.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
| 0.2 | 0.6 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.2 | 0.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 | 18.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 14.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.2 | 0.4 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.2 | 4.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 2.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.6 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 0.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 2.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.2 | 0.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 | 1.0 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 | 0.8 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 | 8.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.2 | 0.8 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 1.0 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 | 0.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.2 | 0.2 | GO:0051464 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
| 0.2 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.2 | 1.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.2 | 1.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.2 | 2.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.2 | 1.0 | GO:1902075 | cellular response to salt(GO:1902075) cellular response to sodium arsenite(GO:1903936) |
| 0.2 | 1.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.2 | 1.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 1.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 1.8 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.2 | 4.3 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 8.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.2 | 1.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.2 | 0.6 | GO:1903565 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.2 | 2.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.2 | 0.8 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 4.2 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.2 | 1.5 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 0.6 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.2 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 2.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 | 0.6 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.2 | 0.8 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 | 0.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.2 | 1.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) response to carbon monoxide(GO:0034465) |
| 0.2 | 8.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.2 | 2.4 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.2 | 0.7 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.2 | 6.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.2 | 0.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.2 | 3.0 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.2 | 3.2 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.2 | 1.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.2 | 5.8 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.2 | 3.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 3.9 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
| 0.2 | 2.2 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.2 | 1.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 1.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.2 | 1.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 | 3.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.2 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.2 | 2.7 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 | 0.5 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.2 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.2 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
| 0.2 | 7.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 | 3.7 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.2 | 0.5 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.2 | 3.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.2 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 1.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 | 0.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.2 | 1.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.2 | 0.6 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.2 | 0.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 4.2 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.2 | 1.8 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.2 | 1.6 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.2 | 0.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) intestinal epithelial structure maintenance(GO:0060729) |
| 0.2 | 1.3 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
| 0.2 | 0.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 | 0.2 | GO:0060405 | regulation of penile erection(GO:0060405) |
| 0.2 | 1.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.2 | 1.4 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.2 | 0.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 1.5 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.2 | 1.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.2 | 0.5 | GO:1901254 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.2 | 0.8 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.2 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.5 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 | 2.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.2 | 0.6 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.2 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 5.2 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.1 | 0.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 | 0.4 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 2.4 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 0.1 | 1.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.1 | 0.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 | 1.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 2.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 1.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 | 1.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 | 4.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 5.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.6 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 3.9 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
| 0.1 | 0.4 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 2.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 | 3.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.6 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 0.1 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.6 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.1 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 5.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.1 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 | 0.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 0.1 | 1.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.8 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 | 0.4 | GO:0075732 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.1 | 0.7 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 | 1.8 | GO:1902284 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 | 0.1 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.1 | 1.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 0.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 | 0.9 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.1 | 0.8 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.1 | 0.4 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 | 2.4 | GO:0006972 | hyperosmotic response(GO:0006972) |
| 0.1 | 0.1 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.1 | 0.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 0.9 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.1 | 0.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.1 | 1.3 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 0.1 | 4.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.1 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 0.5 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.4 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 | 0.5 | GO:0019605 | butyrate metabolic process(GO:0019605) |
| 0.1 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.1 | 0.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.1 | 0.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 0.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.1 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 | 0.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.4 | GO:1900175 | regulation of nodal signaling pathway(GO:1900107) regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 | 0.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 1.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 0.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 1.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 | 1.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 1.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 0.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.1 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 1.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 0.1 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
| 0.1 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 1.2 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 2.2 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 2.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
| 0.1 | 1.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.1 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 1.5 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 | 0.5 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 | 4.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 | 0.7 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.5 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 | 3.5 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) |
| 0.1 | 3.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 | 2.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 7.1 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.2 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.4 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.1 | 0.9 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.1 | 3.9 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 2.5 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.1 | 0.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.1 | 0.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 1.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.1 | 2.5 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.1 | 0.6 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
| 0.1 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.1 | 0.6 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.1 | 1.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 1.2 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 | 0.6 | GO:0060356 | leucine import(GO:0060356) |
| 0.1 | 0.9 | GO:0042904 | ureter maturation(GO:0035799) 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 0.9 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.1 | 0.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 | 0.3 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.1 | 1.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.1 | 0.4 | GO:0006405 | RNA export from nucleus(GO:0006405) |
| 0.1 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 2.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 2.9 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
| 0.1 | 0.5 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.6 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 1.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.7 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 | 0.4 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 | 0.2 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.1 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 2.6 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.1 | 1.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.3 | GO:0007343 | egg activation(GO:0007343) |
| 0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 | 0.7 | GO:0010470 | regulation of gastrulation(GO:0010470) |
| 0.1 | 0.3 | GO:0019376 | galactolipid catabolic process(GO:0019376) |
| 0.1 | 0.2 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 | 0.1 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.1 | 0.2 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.1 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 | 2.0 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.2 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.1 | 0.5 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.1 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.1 | 0.9 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 1.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.5 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 | 1.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
| 0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.1 | 0.2 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.1 | 0.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 3.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.4 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.1 | 0.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 0.1 | GO:0060437 | lung growth(GO:0060437) |
| 0.1 | 1.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.7 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 1.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 0.4 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 | 0.6 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.1 | 0.2 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 | 0.7 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.2 | GO:0060739 | bud outgrowth involved in lung branching(GO:0060447) mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 | 0.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.2 | GO:0097698 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) DNA dephosphorylation(GO:0098502) |
| 0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.1 | 11.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 5.1 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 | 1.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 0.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.1 | 2.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 0.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 3.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 | 0.3 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.1 | 0.3 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 2.3 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.1 | 7.6 | GO:0006415 | translational termination(GO:0006415) |
| 0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 0.1 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 | 0.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.1 | 1.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
| 0.1 | 1.8 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.1 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.1 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
| 0.1 | 0.2 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.2 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 0.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.1 | 0.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 0.1 | 0.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.1 | GO:1903401 | L-lysine transmembrane transport(GO:1903401) |
| 0.1 | 0.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.1 | 1.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.1 | 0.7 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 3.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 3.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.1 | 0.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 | 0.2 | GO:1904640 | response to methionine(GO:1904640) |
| 0.1 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
| 0.1 | 0.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 0.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.2 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 | 0.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 2.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 | 2.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.6 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.6 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 6.4 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.1 | 0.5 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 | 1.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 | 1.2 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.1 | 0.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
| 0.1 | 4.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.1 | 0.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 1.0 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.6 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.1 | 0.7 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 1.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.5 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.0 | 1.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 | 1.1 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 0.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.0 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 | 0.5 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 4.7 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.0 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.0 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.0 | 1.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.0 | 0.5 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.0 | 0.1 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 1.4 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.0 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.0 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.0 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 | 3.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.4 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 | 0.8 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.0 | 0.5 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.0 | 0.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.0 | 0.2 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 | 1.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.0 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.0 | 0.3 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.0 | 1.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.0 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 | 0.8 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
| 0.0 | 1.0 | GO:1901998 | toxin transport(GO:1901998) |
| 0.0 | 0.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 | 3.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.0 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 | 0.4 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.6 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.0 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 | 0.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 | 0.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.0 | 0.8 | GO:0006541 | glutamine metabolic process(GO:0006541) |
| 0.0 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.0 | 1.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
| 0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.0 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 1.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.0 | 0.3 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.0 | 0.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 | 0.3 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 | 0.5 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.0 | 0.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.0 | 0.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 0.0 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.0 | 0.8 | GO:0048753 | pigment granule organization(GO:0048753) |
| 0.0 | 0.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.0 | 0.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.0 | 4.4 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.0 | 0.1 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.0 | 0.1 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.0 | 0.1 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 | 1.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 1.1 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.0 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 | 0.4 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.0 | 0.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.0 | 0.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.0 | 0.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.5 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.0 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 | 0.4 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
| 0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.0 | 0.4 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 2.5 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 0.0 | 0.2 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) negative regulation of growth of symbiont in host(GO:0044130) |
| 0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 1.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.0 | 1.1 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.0 | 0.3 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.0 | 0.3 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
| 0.0 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.0 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.0 | 0.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 | 0.3 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.0 | 0.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.0 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.0 | 0.5 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
| 0.0 | 0.1 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.0 | 0.1 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 | 0.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 0.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 0.0 | 0.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
| 0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.0 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.0 | GO:0035565 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.0 | 0.0 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.1 | GO:0046541 | saliva secretion(GO:0046541) |
| 0.0 | 0.4 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.0 | 0.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.2 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.0 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
| 0.0 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.3 | GO:0007618 | mating(GO:0007618) |
| 0.0 | 0.3 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.0 | 0.1 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.0 | 0.0 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.0 | 0.2 | GO:0001824 | blastocyst development(GO:0001824) |
| 0.0 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
| 0.0 | 0.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.0 | 0.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.0 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 | 0.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 18.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 2.1 | 6.3 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 1.6 | 4.9 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
| 1.6 | 3.2 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 1.5 | 10.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 1.3 | 7.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.3 | 5.0 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 1.3 | 11.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.1 | 7.6 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 1.1 | 7.5 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 1.0 | 3.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 1.0 | 16.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.0 | 4.9 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.9 | 6.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.9 | 1.7 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.8 | 5.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.8 | 5.7 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.7 | 2.1 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.7 | 6.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.7 | 7.9 | GO:0070449 | elongin complex(GO:0070449) |
| 0.6 | 10.7 | GO:0032059 | bleb(GO:0032059) |
| 0.6 | 5.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.6 | 2.4 | GO:0001652 | granular component(GO:0001652) |
| 0.6 | 7.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.6 | 1.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.5 | 6.4 | GO:0097413 | Lewy body(GO:0097413) |
| 0.5 | 5.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.5 | 3.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.5 | 2.6 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.5 | 2.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.5 | 34.1 | GO:0015030 | Cajal body(GO:0015030) |
| 0.5 | 1.4 | GO:0030689 | Noc complex(GO:0030689) |
| 0.5 | 1.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.5 | 3.8 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.5 | 8.9 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.5 | 7.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.4 | 1.8 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.4 | 5.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.4 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.4 | 5.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.4 | 6.8 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.4 | 3.1 | GO:0031415 | NatA complex(GO:0031415) |
| 0.4 | 2.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.4 | 15.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.3 | 3.1 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.3 | 21.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.3 | 2.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 2.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 11.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.3 | 1.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 7.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.3 | 3.2 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.3 | 1.3 | GO:1990879 | CST complex(GO:1990879) |
| 0.3 | 1.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.3 | 0.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.3 | 1.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.3 | 2.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 2.6 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.3 | 1.4 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.3 | 5.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 1.5 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.3 | 2.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.3 | 1.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.2 | 1.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 3.7 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 2.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.2 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 2.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 2.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 4.7 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 4.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.2 | 0.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.2 | 2.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 3.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 0.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 0.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.2 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 1.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.8 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 5.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 4.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 0.6 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.2 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 7.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.2 | 1.5 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 0.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.2 | 2.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.2 | 3.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 0.5 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.2 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.2 | 3.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 2.5 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 1.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 75.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.2 | 2.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 0.5 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 2.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 3.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 2.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.2 | 2.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.4 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 4.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.1 | 0.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 0.7 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.1 | 2.2 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 2.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 1.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.1 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 2.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 2.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.5 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 31.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 1.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 0.6 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.1 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.1 | 0.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 1.4 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.1 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.3 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 9.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 0.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 1.8 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 0.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 9.0 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.1 | 0.3 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 1.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.1 | 2.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.1 | 1.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.3 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.1 | 5.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 1.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 1.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.1 | 0.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 2.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.1 | 9.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 1.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 10.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 0.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.1 | 1.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 2.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.1 | 5.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 0.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
| 0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 3.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 2.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 1.9 | GO:0042627 | chylomicron(GO:0042627) |
| 0.1 | 0.3 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.1 | 0.4 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 0.2 | GO:0005592 | collagen type XI trimer(GO:0005592) |
| 0.1 | 6.8 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 3.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 0.1 | 0.2 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.1 | 4.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 0.8 | GO:0048500 | signal recognition particle(GO:0048500) |
| 0.1 | 0.2 | GO:0033167 | ARC complex(GO:0033167) |
| 0.1 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.4 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 1.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 2.1 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 2.2 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 27.4 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) |
| 0.1 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
| 0.0 | 0.4 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.0 | 0.6 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 0.0 | 2.8 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.3 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.0 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.0 | 7.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 0.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.0 | 1.9 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.0 | 5.5 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 7.2 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.9 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 0.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.0 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 15.3 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 1.8 | GO:0043034 | costamere(GO:0043034) |
| 0.0 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 14.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.0 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.0 | 0.0 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
| 0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.0 | 1.0 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.0 | 4.5 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 1.6 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.0 | 2.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.0 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.0 | 1.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.0 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
| 0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 3.7 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 2.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.1 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.0 | 1.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 1.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
| 0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.0 | 0.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 1.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.0 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.0 | 0.1 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.0 | 1.6 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 1.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.1 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.0 | 0.1 | GO:1902562 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.7 | 32.0 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 9.2 | 27.7 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 3.8 | 18.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 3.2 | 9.7 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 3.1 | 9.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 3.0 | 60.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 2.8 | 8.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 2.2 | 6.7 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 2.1 | 6.3 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 2.1 | 6.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 1.8 | 10.9 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.4 | 8.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 1.3 | 10.7 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 1.3 | 6.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 1.3 | 5.1 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 1.3 | 6.3 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 1.2 | 4.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.2 | 3.6 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 1.1 | 4.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 1.1 | 5.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 1.1 | 3.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.0 | 8.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.9 | 7.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.9 | 3.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.8 | 3.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.8 | 3.3 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.8 | 2.4 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.8 | 2.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.8 | 9.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.8 | 10.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.8 | 3.0 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 0.8 | 2.3 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.8 | 10.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.7 | 2.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.7 | 2.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.7 | 5.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.7 | 2.1 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.7 | 2.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.7 | 2.8 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.7 | 6.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.7 | 2.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.7 | 19.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.7 | 2.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.7 | 5.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.6 | 3.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.6 | 2.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.6 | 3.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.6 | 3.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.6 | 8.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.6 | 1.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.6 | 6.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.6 | 2.4 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.6 | 1.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.6 | 4.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.6 | 3.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.6 | 9.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.6 | 5.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.6 | 6.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 3.9 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 3.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.5 | 3.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.5 | 2.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.5 | 3.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.5 | 2.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.5 | 1.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.5 | 2.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.5 | 1.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.5 | 3.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.5 | 11.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.5 | 2.0 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.5 | 1.9 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.5 | 1.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
| 0.5 | 8.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.5 | 3.8 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.5 | 1.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.5 | 3.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.5 | 1.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.5 | 0.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.5 | 0.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.4 | 3.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.4 | 5.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.4 | 2.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.4 | 1.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 2.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.4 | 1.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.4 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 1.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.4 | 1.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.4 | 6.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.4 | 1.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.4 | 1.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.4 | 1.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 0.4 | 2.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 1.1 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.4 | 1.1 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 1.4 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.3 | 2.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 2.1 | GO:0035473 | lipase binding(GO:0035473) |
| 0.3 | 1.0 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.3 | 3.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.3 | 1.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.3 | 1.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 7.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 1.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 1.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.3 | 6.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.3 | 2.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 2.0 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.3 | 2.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.3 | 1.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.3 | 0.9 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.3 | 3.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.3 | 7.2 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.3 | 0.9 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 3.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.3 | 2.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.3 | 1.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 1.8 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.3 | 1.2 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.3 | 2.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 4.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.3 | 1.4 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.3 | 0.8 | GO:0000035 | acyl binding(GO:0000035) |
| 0.3 | 1.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.3 | 0.6 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.3 | 4.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.3 | 0.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.3 | 8.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.3 | 1.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.3 | 1.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 4.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 2.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.3 | 0.8 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.3 | 3.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 2.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.3 | 1.6 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.3 | 1.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 4.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.3 | 0.8 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 2.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.3 | 1.0 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.2 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.2 | 9.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 1.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.2 | 1.2 | GO:0097108 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
| 0.2 | 3.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 1.7 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.2 | 13.6 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.2 | 1.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 0.9 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 2.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 0.9 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.2 | 2.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.2 | 4.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.2 | 3.9 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 2.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.2 | 2.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 1.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.2 | 2.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.2 | 7.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
| 0.2 | 2.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 1.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.2 | 5.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.2 | 0.6 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.2 | 1.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 1.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.2 | 0.9 | GO:0043273 | CTPase activity(GO:0043273) |
| 0.2 | 0.4 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.2 | 4.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 1.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.2 | 1.2 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.2 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.0 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.2 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.2 | 33.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 0.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 1.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.2 | 2.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 0.9 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.2 | 6.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.2 | 2.2 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.2 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 3.9 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.2 | 23.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 0.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 2.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.2 | 2.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 5.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.2 | 0.8 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 0.2 | 4.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.2 | 0.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 0.8 | GO:0034618 | arginine binding(GO:0034618) |
| 0.2 | 0.7 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.2 | 1.3 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.2 | 1.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.2 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.2 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.2 | 2.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.2 | 0.5 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.2 | 0.8 | GO:0004803 | transposase activity(GO:0004803) |
| 0.2 | 4.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.2 | 3.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 1.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.2 | 7.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.2 | 1.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.2 | 8.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.2 | 3.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.2 | 1.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.2 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 9.0 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 1.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.1 | 7.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 3.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 0.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 2.6 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.1 | 0.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.1 | 0.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.1 | 1.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.1 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 2.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 2.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.1 | 1.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 1.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 2.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.1 | 0.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.1 | 0.9 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 2.2 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 1.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 3.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 17.4 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
| 0.1 | 3.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 2.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.5 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.5 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.1 | 1.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 5.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.9 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.1 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 2.6 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 7.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 3.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.1 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 0.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.1 | 4.9 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.2 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.8 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.1 | 3.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.4 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 6.4 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.1 | 12.1 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.1 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 5.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 0.4 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.4 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 1.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 0.5 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 5.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.1 | 1.3 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.8 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.4 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.1 | 2.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 1.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.4 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.2 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.1 | 4.8 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.1 | 0.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 0.3 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.1 | 1.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.1 | 3.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 1.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 2.6 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 4.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.1 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.1 | 2.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.1 | 2.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.6 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.1 | 5.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 1.1 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 1.0 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 0.2 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.1 | 0.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 5.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 2.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 0.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 0.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 2.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 2.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.1 | 2.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.1 | 3.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 0.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 1.1 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 1.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 0.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.1 | 0.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 0.9 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.1 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 1.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.1 | 0.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.4 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 0.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.1 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 2.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.1 | 1.4 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.1 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 2.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 7.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.1 | 0.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 1.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 0.4 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.1 | 0.2 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.1 | 13.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.1 | 1.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 1.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 0.7 | GO:0015250 | water channel activity(GO:0015250) |
| 0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 0.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.0 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.0 | 0.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.0 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.0 | 1.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 4.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.0 | 0.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 1.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 1.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.0 | 0.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
| 0.0 | 6.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.0 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.0 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 1.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.0 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 0.3 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.0 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.0 | 0.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 1.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.2 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.0 | 0.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.0 | 7.3 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 14.9 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.0 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.0 | 0.5 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 15.0 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
| 0.0 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 2.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.0 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 0.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.0 | 10.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 1.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 0.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.0 | 0.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.0 | 29.9 | GO:0003723 | RNA binding(GO:0003723) |
| 0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.1 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.0 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.0 | 0.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 1.2 | GO:0070851 | growth factor receptor binding(GO:0070851) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.0 | 0.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.0 | 0.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.0 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.0 | 0.3 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 1.3 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 0.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 0.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.0 | 3.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.0 | 0.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 15.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.5 | 16.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.5 | 69.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.5 | 1.8 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.4 | 3.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 5.5 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.3 | 7.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 6.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 3.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.2 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 8.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 11.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 4.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 3.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 2.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 4.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 3.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 4.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.2 | 3.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.2 | 11.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 15.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 16.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.1 | 1.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 6.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 6.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 6.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 1.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 3.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.1 | 0.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 2.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 2.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 3.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 4.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 3.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.1 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 5.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 0.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 2.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 2.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 6.1 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 7.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 4.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 2.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 2.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.0 | 0.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 1.0 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 1.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 0.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 1.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 1.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 2.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 1.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 0.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.6 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
| 0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 60.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 1.1 | 4.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 1.1 | 22.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.8 | 16.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.7 | 0.7 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.6 | 62.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.5 | 9.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.5 | 8.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.5 | 4.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.5 | 27.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.4 | 16.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.4 | 3.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.4 | 16.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.4 | 7.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.3 | 8.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.3 | 3.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 20.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 7.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.3 | 18.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 15.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 7.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 4.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 5.3 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.2 | 5.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 8.7 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.2 | 8.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 3.4 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.2 | 17.9 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
| 0.2 | 6.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.2 | 2.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 6.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.2 | 4.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 2.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.2 | 9.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 5.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 7.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 7.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.2 | 0.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.2 | 3.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 4.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.2 | 0.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 4.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 7.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 0.5 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 5.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 1.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.2 | 7.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.2 | 2.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.2 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 2.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 6.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 3.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.1 | 17.4 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 2.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 0.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 1.4 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 2.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 3.6 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.1 | 1.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.1 | 2.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.1 | 1.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 1.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 2.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 4.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.1 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 1.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 1.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 2.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 1.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 0.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 2.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 5.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 0.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 4.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 2.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 3.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 2.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 1.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 0.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.1 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.1 | 4.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 2.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 3.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 9.2 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 11.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 0.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.0 | 0.8 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 1.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.0 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.0 | 0.4 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
| 0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.0 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.0 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.0 | 2.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 1.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 0.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.0 | 0.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.0 | 1.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.0 | 2.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.4 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
| 0.0 | 0.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 0.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.4 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
| 0.0 | 0.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 3.0 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 1.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.0 | 0.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 0.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |